What the Drug Industry Can Learn from FDA's Social Media Policy

The FDA recently posted a new social media policy, but it's not for the pharmaceutical industry. The policy is for its own employees (read "FDA Releases a Long-Awaited Social Media Policy").

Like similar policies developed by pharma companies such as Roche (here), FDA's SM policy provides guidance to their employees about how to use social media for personal and professional purposes.

"The FDA encourages the use of social media technologies to enhance communication, collaboration, and information exchange in support of FDA’s mission to protect and promote public health," states the introduction. "This policy applies to FDA employees, contractors, and other personnel acting in an official capacity when using social media to communicate with the public regarding FDA-related matters."

I read "between the lines" to determine if this policy offers any hints as to how the FDA may further regulate pharma's use of social media in the future, especially with regard to correcting/deleting comments posted to its own sites and linking to external third-party sites.

Read more »